A Study on Efficacy and Safety of Topiramate in Maintaining Weight Loss in Obese Patients Following an Intensive, Non-Pharmacologic Weight Loss Program

NCT00236600 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

561

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: topiramate

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.